Tutorials
Neuronetics Inc logo

Neuronetics Inc

$ 4.40 +0.14 (+3.29%) 04:00 PM EST
P/E:
At Loss
P/B:
1.70
Market Cap:
$ 118.90M
Enterprise V:
$ 81.71M
Volume:
206.85K
Avg Vol (2M):
940.82K
Also Trade In:
Volume:
206.85K
Market Cap $:
118.90M
PE Ratio:
At Loss
Avg Vol (2-Month):
940.82K
Enterprise Value $:
81.71M
PB Ratio:
1.70
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Neuronetics Inc
NAICS : 621511 SIC : 8099
3222 Phoenixville Pike, Malvern, PA, USA, 19355
Compare
Compare
CNTG AWH BDSX AKU TRIB XGN SERA CHEK PMD TTOO TMO DHR XSWX:LONN SHSE:603259 IQV ILMN A IDXX MTD LH
Traded in other countries / regions
NRC.Germany STIM.USA
Description
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
Name Current Vs Industry Vs History
Cash-To-Debt 1.84
Equity-to-Asset 0.56
Debt-to-Equity 0.58
Debt-to-EBITDA -1.13
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.24
Distress
Grey
Safe
Beneish M-Score -1.73
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 51.15
9-Day RSI 58.1
14-Day RSI 59.61
6-1 Month Momentum % 13.88
12-1 Month Momentum % -59.48

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.02
Quick Ratio 4.64
Cash Ratio 3.86
Days Inventory 164.68
Days Sales Outstanding 54.26
Days Payable 77.78

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.2

Financials (Next Earnings Date:2022-11-09 Est.)

STIM's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:STIM

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 59.331
EPS (TTM) ($) -1.4
Beta 2.44
Volatility % 77.63
14-Day RSI 59.61
14-Day ATR ($) 0.316645
20-Day SMA ($) 3.9805
12-1 Month Momentum % -59.48
52-Week Range ($) 1.98 - 9.07
Shares Outstanding (Mil) 27.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Neuronetics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More